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A 34-year-old female with a history of advanced pulmonary 
sarcoidosis and right-sided heart failure presented with 
chronic, postprandial right upper quadrant pain, and weight 
loss. Endoscopic biliary drainage was deemed to be the most 
appropriate therapeutic option for her chronic cholecystitis. 
Endoscopic retrograde cholangiopancreatography utilizing 
the SpyGlass cholangioscopy system allowed us to access 
the cystic duct through which the gallbladder was ultimately 
decompressed, via biliary stent placement and gallstone 
irrigation. This is the ﬁ  rst report of SpyScope assisted place-
ment of fully covered self-expandable metal biliary stents into 
the cystic duct enabling deﬁ  nitive treatment of symptomatic 
chronic cholecystitis and cholelithiasis without cholecystec-
tomy. (Gut Liver 2012;6:136-138)
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INTRODUCTION
It is estimated that 25 million American adults have gallstones 
at autopsy.
1 Risk factors for cholelithiasis include age, female 
gender, parity, obesity, rapid weight loss, hypertryglyceridemia, 
genetics, various medications (such as estrogens, clofibrate, and 
ceftriaxone), terminal ileal resection, and gallbladder hypomo-
tility as seen in post-vagotomy and total parenteral nutrition.
2 
Cholelithiasis can be asymptomatic or can lead to complications 
such as biliary colic, choledocholithiasis, and cholecystitis. The 
definitive treatment for symptomatic cholelithiasis and cho-
lecystitis is surgery, with laparoscopic techniques dominating 
over open procedures. It has been estimated that nearly 700,000 
cholecystectomies are performed yearly in the United States.
1 In 
rare cases when cholecystectomy is not feasible, a percutane-
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ous transhepatic approach can be used to drain the gallbladder. 
In recent literature, a new endoscopic approach of draining 
the gallbladder through biliary stents has been described.
3,4 We 
present a case of chronic cholecystitis treated with SpyGlass-
assisted endoscopic gallbladder drainage and gallstone irrigation 
through biliary stents.
CASE REPORT
A 34-year-old female with a history of advanced pulmonary 
sarcoidosis and right-sided heart failure presented with chronic, 
postprandial right upper quadrant pain and weight loss. An 
abdominal ultrasound revealed cholelithiasis and choledocho-
lithiasis with dilatation of the common bile duct (CBD). Endo-
scopic retrograde cholangiopancreatography (ERCP) revealed a 
distal CBD stricture with proximal dilatation of the biliary tree 
and several stones. The stricture was dilated with a 4 cm×30 Fr 
biliary balloon dilatation catheter (Hurricane
TM RX; Boston Sci-
entific, Cork, Ireland). Sphincterotomy was then performed and 
two CBD stones were removed with a 12/15 mm biliary retrieval 
balloon (Extractor
TM RX; Boston Scientific, Cork, Ireland). Re-
peat cholangiogram showed clearance of the CBD and hepatic 
ducts, however, numerous stones were seen in the gallbladder. 
Despite the patient’s young age and persistent symptoms, cho-
lecystectomy was deemed too high risk and was not performed. 
Endoscopic biliary drainage was deemed to be the most appro-
priate therapeutic option.  
Repeat ERCP utilizing the SpyGlass cholangioscopy system 
(SpyGlass Direct Visualization System; Microvasive Endoscopy, 
Boston Scientific Co., Natick, MA, USA), enabled direct visual-
ization of the cystic duct and gallbladder, and a 0.035 in×260 
cm guide wire (Hydra Jagwire
TM; Boston Scientific, Miami, FL, 
USA) was placed into the gallbladder. On fluroscopy the cystic Gutkin E, et al: Endoscopic Gallbladder Drainage and Irrigation  137
duct was approximately 4 mm in diameter and the 10 Fr Spy-
Glass cholangioscopy system was easily advanced into the cys-
tic duct, without need for dilatation. Given these measurements 
we estimated that the cystic duct would safely accommodate the 
7 Fr delivery system of the biliary self expanding metal stents 
(SEMS). In order to traverse the entire length of the cystic duct, 
two overlapping 10×80 mm fully covered self-expanding metal 
biliary stents (WallFlex
TM Biliary; Boston Scientific, Galway, 
Ireland) were placed over the guide wire into the gallbladder. 
Subsequently, a third 10×80 mm fully covered SEMS (Wall-
Flex
TM Biliary, Boston Scientific, Galway, Ireland) was placed 
into the CBD (Fig. 1). The distal CBD stricture appreciated on 
the first ERCP had resolved post biliary balloon dilatation and 
the three biliary stents were easily advanced into place. Numer-
ous small stones were noted to drain from the gallbladder after 
stent placement. The gallbladder was then thoroughly irrigated 
by advancing the SpyScope with an attached irrigation system 
(EndoGater
TM; Byrne Medical Inc., Conroe, TX, USA) resulting 
in clearance of additional stones (Fig. 2). Repeat cholangiogram 
revealed a contracted gallbladder with no filling defects in the 
CBD or the gallbladder. The patient was a poor surgical can-
didate, and in lieu of cholecystectomy, we chose fully covered 
metal stents to allow for the irrigation and removal of all the 
gallstones, as well as a longer period of drainage. Plastic biliary 
stents would allow for drainage, but not stone removal. The ful-
ly covered SEM biliary stents were chosen for the CBD and gall-
bladder in order to allow for the possibility of future removal. 
The stents were kept in place post irrigation to ensure continued 
drainage.
The patient did well post procedure and was discharged home 
on a regular diet several days later. An abdominal ultrasound 
at one month follow-up revealed a normal appearing gallblad-
der without evidence of stones or sludge. At 5-month follow-
up the patient had no abdominal complaints and had normal 
liver function tests. At 1-year follow-up, the patient was pain 
free but the plan for stent removal was halted by her ongoing 
pulmonary issues.
DISCUSSION
Surgical cholecystectomy remains the gold standard for treat-
ment of symptomatic cholelithiasis and cholecystitis. In patients 
considered too high risk for surgery, percutaneous transhepatic 
or endoscopic gallbladder drainage can be entertained. A re-
cent systematic review by Itoi et al.
3 revealed that endoscopic 
gallbladder stenting had a technical success rate of 96% and 
a clinical success rate of 88% which compared favorably with 
percutaneous transhepatic gallbladder drainage (98% and 90%, 
respectively). In 2008, Itoi et al.
4 reported a 97% clinically fa-
vorable response in patients who underwent endoscopic trans-
papillary gallbladder drainage for acute cholecystitis. Endo-
scopic transpapillary gallbladder cannulation was first described 
in 1984.
5 With the advent of SpyGlass, definitive visualization 
and cannulation of the cystic duct and gallbladder can occur 
with ease. Several cases of SpyGlass-directed cannulation of the 
cystic duct have been described in the literature.
6 We describe 
a novel technique of SpyGlass-assisted cystic duct stenting us-
ing fully covered biliary stents, allowing for improved drainage 
of gallstones from the gallbladder. Using SEMSs allowed for 
drainage of the gallbladder and also created a conduit through 
which the SpyGlass scope, with the irrigation system, could be 
used to irrigate and successfully clear the gallbladder. This is 
the first report of SpyGlass-assisted placement of fully covered 
biliary stents into the cystic duct, enabling definitive treatment 
of symptomatic chronic cholecystitis and cholelithiasis without 
cholecystectomy.  
Fig. 2. A gallstone exiting the biliary stent. Fig. 1. A fluoroscopic image of gallbladder stents and the common 
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